Nephroprotective potential of human albumin infusion: A narrative review

Gastroenterology Research and Practice

Volumn 2015, Issue , 2015, Pages

  Wiedermann, Christian J ^a,b   Joannidis, Michael ^c  

^a CENTRAL HOSPITAL OF BOLZANO   (Italy)

^b Interdisciplinary Medical Research Center South Tyrol (IMREST)   (Italy)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMIKACIN; AMINOGLYCOSIDE; ANTIBIOTIC AGENT; DIURETIC AGENT; DOPAMINE; FUROSEMIDE; HUMAN ALBUMIN; PHENYLEPHRINE; PLACEBO; SERUM ALBUMIN; SODIUM CHLORIDE; VASOCONSTRICTOR AGENT;

ACUTE KIDNEY FAILURE; ALBUMIN BLOOD LEVEL; ANTIBIOTIC THERAPY; BACTERIAL PERITONITIS; CLINICAL TRIAL (TOPIC); COLLOID; CONSERVATIVE TREATMENT; CRITICALLY ILL PATIENT; DISEASE SEVERITY; DIURETIC THERAPY; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG INFUSION; FLUID BALANCE; FLUID RESUSCITATION; FLUID THERAPY; GLOMERULUS FILTRATION; HEMODYNAMICS; HUMAN; HYPERVOLEMIA; HYPOALBUMINEMIA; KIDNEY BLOOD FLOW; KIDNEY FUNCTION; LIVER CIRRHOSIS; MICROCIRCULATION; MORBIDITY; MORTALITY; NEPHROTOXICITY; PATIENT SAFETY; PHARMACODYNAMICS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL PROTECTION; RENAL REPLACEMENT THERAPY; REVIEW; RISK FACTOR; SEPSIS; SEPTIC SHOCK; VASODILATATION;

EID: 84934941774     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2015/912839     Document Type: Review

References (45)

1. R. P. Dellinger, M. M. Levy, A. Rhodes et al., "Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012, " Critical Care Medicine, vol. 41, no. 2, pp. 580-637, 2013.
2. F. M. Brunkhorst, C. Engel, F. Bloos et al., "Intensive insulin therapy and pentastarch resuscitation in severe sepsis, " The New England Journal of Medicine, vol. 358, no. 2, pp. 125-139, 2008.
3. B. Guidet, O. Martinet, T. Boulain et al., "Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0. 4 vs. 0. 9% NaCl fluid replacement in patients with severe sepsis: the CRYSTMAS study, " Critical Care, vol. 16, no. 3, p. R94, 2012.
4. A. Perner, N. Haase, A. B. Guttormsen et al., "Hydroxyethyl starch 130/0. 42 versus Ringer's acetate in severe sepsis, "The New England Journal of Medicine, vol. 367, no. 2, pp. 124-134, 2012.
5. J. A. Myburgh, S. Finfer, R. Bellomo et al., "Hydroxyethyl starch or saline for fluid resuscitation in intensive care, " The New England Journal ofMedicine, vol. 367, no. 20, pp. 1901-1911, 2012.
6. G. J. Quinlan, G. S. Martin, and T. W. Evans, "Albumin: biochemical properties and therapeutic potential, " Hepatology, vol. 41, no. 6, pp. 1211-1219, 2005.
7. S. Finfer, R. Bellomo, N. Boyce, J. French, J. Myburgh, and R. Norton, "A comparison of albumin and saline for fluid resuscitation in the intensive care unit, "The New England Journal of Medicine, vol. 350, no. 22, pp. 2247-2256, 2004.
8. SAFE Study Investigators, S. Finfer, S. McEvoy et al., "Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis, " Intensive Care Medicine, vol. 37, no. 1, pp. 86-96, 2011.
9. A. P. Delaney, A. Dan, J. McCaffrey, and S. Finfer, "The role of albumin as a resuscitation fluid for patients with sepsis: A systematic review and meta-analysis, " Critical Care Medicine, vol. 39, no. 2, pp. 386-391, 2011.
10. J. L. Vincent, R. J. Navickis, and M. M. Wilkes, "Morbidity in hospitalized patients receiving human albumin: ameta-analysis of randomized, controlled trials, " Critical CareMedicine, vol. 32, no. 10, pp. 2029-2038, 2004.
11. P. Caironi, G. Tognoni, S. Masson et al., "Albumin replacement in patients with severe sepsis or septic shock, " The New England Journal of Medicine, vol. 370, no. 15, pp. 1412-1421, 2014.
12. "Albumin Replacement in Severe Sepsis or Septic Shock, " New England Journal of Medicine, vol. 371, no. 1, pp. 83-84, 2014.
13. A. Patel, M. A. Laffan, U. Waheed, and S. J. Brett, "Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of allcause mortality, " The BritishMedical Journal, vol. 349, no. 7968, p. g4561, 2014.
14. S. L. Shafer and M. M. Wilkes, "Randomised trials of human albumin for adults with sepsis: systematic review and metaanalysis with trial sequential analysis of all-causemortality, "The British Medical Journal, vol. 349, Article IDg4561, 2014.
15. C. J. Wiedermann, "Double-counted mortality data bias in the 2014 meta-analysis of Patel and co-workers, " http://www. bmj. com/content/349/bmj. g4561/rr/762598.
16. B. Rochwerg, W. Alhazzani, A. Sindi et al., "Fluid resuscitation in sepsis: a systematic review and network meta-analysis, " Annals of Internal Medicine, vol. 161, no. 5, pp. 347-355, 2014.
17. M. Jacob, O. Paul, L. Mehringer et al., "Albumin augmentation improves condition of guinea pig hearts after 4 hr of cold ischemia, " Transplantation, vol. 87, no. 7, pp. 956-965, 2009.
18. R. Larsen, R. Gozzelino, V. Jeney et al., "A central role for free heme in the pathogenesis of severe sepsis, " Science Translational Medicine, vol. 2, no. 51, Article ID51ra71, 2010.
19. M. Bauer, K. Huse, U. Settmacher, and R. A. Claus, "The heme oxygenase-carbon monoxide system: regulation and role in stress response and organ failure, " Intensive Care Medicine, vol. 34, no. 4, pp. 640-648, 2008.
20. C.-E. Ha and N. V. Bhagavan, "Novel insights into the pleiotropic effects of human serum albumin in health and disease, " Biochimica et Biophysica Acta, vol. 1830, no. 12, pp. 5486-5493, 2013.
21. J. Ghuman, P. A. Zunszain, I. Petitpas, A. A. Bhattacharya, M. Otagiri, and S. Curry, "Structural basis of the drug-binding specificity of human serum albumin, " Journal of Molecular Biology, vol. 353, no. 1, pp. 38-52, 2005.
22. T. W. Evans, "Review article: albumin as a drug-biological effects of albumin unrelated to oncotic pressure, " Alimentary Pharmacology and Therapeutics, Supplement, vol. 16, supplement 5, pp. 6-11, 2002.
23. C. J. Wiedermann, W. Wiedermann, and M. Joannidis, "Hypoalbuminemia and acute kidney injury: a meta-analysis of observational clinical studies, " Intensive Care Medicine, vol. 36, no. 10, pp. 1657-1665, 2010.
24. R. Dixon and N. J. Brunskill, "Activation of mitogenic pathways by albumin in kidney proximal tubule epithelial cells: implications for the pathophysiology of proteinuric states, " Journal of the American Society of Nephrology, vol. 10, no. 7, pp. 1487-1497, 1999.
25. A. M. Contreras, M. Ramirez, L. Cueva, S. Alvarez, R. de Loza, and G. Gamba, "Low serum albumin and the increased risk of amikacin nephrotoxicity, " Revista de Investigación Cĺnica, vol. 46, no. 1, pp. 37-43, 1994.
26. D. Fliser, I. Zurbrüggen, E. Mutschler et al., "Coadministration of albumin and furosemide in patients with the nephrotic syndrome, " Kidney International, vol. 55, no. 2, pp. 629-634, 1999.
27. G. S. Martin, M. Moss, A. P. Wheeler, M. Mealer, J. A. Morris, and G. R. Bernard, "A randomized, controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury, " Critical Care Medicine, vol. 33, no. 8, pp. 1681-1687, 2005.
28. M.-J. Dubois, C. Orellana-Jimenez, C. Melot et al., "Albumin administration improves organ function in critically ill hypoalbuminemic patients: a prospective, randomized, controlled, pilot study, " Critical Care Medicine, vol. 34, no. 10, pp. 2536-2540, 2006.
29. C. Uhlig, P. L. Silva, S. Deckert, J. Schmitt, and M. G. de Abreu, "Albumin versus crystalloid solutions in patients with the acute respiratory distress syndrome: a systematic review and metaanalysis, " Critical Care, vol. 18, no. 1, article R10, 2014.
30. N. J. Glassford and R. Bellomo, "Acute kidney injury: how can we facilitate recovery" Current Opinion in Critical Care, vol. 17, no. 6, pp. 562-568, 2011.
31. M. Legrand, C. Dupuis, C. Simon et al., "Association between systemic hemodynamics and septic acute kidney injury in critically ill patients: a retrospective observational study, " Critical Care, vol. 17, no. 6, article R278, 2013.
32. J. D. Firth, A. E. G. Raine, and J. G. G. Ledingham, "Raised venous pressure: a direct cause of renal sodium retention in oedema" The Lancet, vol. 1, no. 8593, pp. 1033-1035, 1988.
33. J. R. Prowle, J. E. Echeverri, E. V. Ligabo, C. Ronco, and R. Bellomo, "Fluid balance and acute kidney injury, " Nature Reviews Nephrology, vol. 6, no. 2, pp. 107-115, 2010.
34. M. G. Vidal, J. R. Weisser, F. Gonzalez et al., "Incidence and clinical effects of intra-abdominal hypertension in critically ill patients, " Critical Care Medicine, vol. 36, no. 6, pp. 1823-1831, 2008.
35. J. R. Prowle, C. J. Kirwan, and R. Bellomo, "Fluid management for the prevention and attenuation of acute kidney injury, " Nature Reviews Nephrology, vol. 10, no. 1, pp. 37-47, 2014.
36. M. E. Grams, M. M. Estrella, J. Coresh, R. G. Brower, and K. D. Liu, "Fluid balance, diuretic use, and mortality in acute kidney injury, " Clinical Journal of the American Society of Nephrology, vol. 6, no. 5, pp. 966-973, 2011.
37. I. J. A. Dawidson, Z. F. Sandor, L. Coorpender et al., "Intraoperative albumin administration affects the outcome of cadaver renal transplantation, " Transplantation, vol. 53, no. 4, pp. 774-782, 1992.
38. B. A. Pockaj, J. C. Yang, M. T. Lotze et al., "A prospective randomized trial evaluating colloid versus crystalloid resuscitation in the treatment of the vascular leak syndrome associated with interleukin-2 therapy, " Journal of ImmunotherapywithEmphasis on Tumor Immunology, vol. 15, no. 1, pp. 22-28, 1994.
39. A. P. Stevens, V. Hlady, and R. O. Dull, "Fluorescence correlation spectroscopy can probe albumin dynamics inside lung endothelial glycocalyx, " The American Journal of Physiology: Lung Cellular and Molecular Physiology, vol. 293, no. 2, pp. L328-L335, 2007.
40. M. Jacob, D. Bruegger, M. Rehm, U. Welsch, P. Conzen, and B. F. Becker, "Contrasting effects of colloid and crystalloid resuscitation fluids on cardiac vascular permeability, " Anesthesiology, vol. 104, no. 6, pp. 1223-1231, 2006.
41. R. A. Kozar, Z. Peng, R. Zhang et al., "Plasma restoration of endothelial glycocalyx in a rodent model of hemorrhagic shock, " Anesthesia and Analgesia, vol. 112, no. 6, pp. 1289-1295, 2011.
42. M. Bernardi, P. Caraceni, R. J. Navickis, and M. M. Wilkes, "Albumin infusion in patients undergoing large-volume paracentesis: a meta-analysis of randomized trials, " Hepatology, vol. 55, no. 4, pp. 1172-1181, 2012.
43. C. J. Wiedermann, S. Dunzendorfer, L. U. Gaioni, F. Zaraca, and M. Joannidis, "Hyperoncotic colloids and acute kidney injury: a meta-analysis of randomized trials, " Critical Care, vol. 14, no. 5, article R191, 2010.
44. F. Salerno, R. J. Navickis, and M. M. Wilkes, "Albumin infusion improves outcomes of patients with spontaneous bacterial peritonitis: a meta-analysis of randomized trials, " Clinical Gastroenterology and Hepatology, vol. 11, no. 2, pp. 123-130, 2013.
45. D. J. Cooper, J. Myburgh, S. Heritier et al., "Albumin resuscitation for traumatic brain injury: is intracranial hypertension the cause of increased mortality" Journal of Neurotrauma, vol. 30, no. 7, pp. 512-518, 2013.